Moxibustion enhances anti-inflammatory and analgesic effects of RA drugs

Moxibustion can enhance the anti-inflammatory and analgesic effects of conventional medicine in patients with rheumatoid arthritis (RA), Chinese authors report. Their study involved 46 RA patients who were randomly assigned to a control group treated with drug therapy (methotrexate or leflunomide), or a treatment group who received drugs plus moxibustion at ZusanliST-36, ShenshuBL-23 and ashi points. Compared with the control group, the treatment group showed significant improvement in clinical symptoms. Significant differences in levels of pro-inflammatory cytokines (TNF-α and IL-1β) were also found between the groups after eight weeks of treatment, suggesting that moxibustion enhanced the anti-inflammatory effect of drug therapy. Serum biomarkers of angiogenesis (HIF-1α and VEGF) were found to be decreased in the treatment group after therapy, suggesting that moxibustion could also inhibit angiogenesis, a core pathophysiological feature of the inflammation of the synovium which is characteristic of RA. Specific RA-associated serum markers did not show significant differences between the two groups.

Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis. Pain Res Manag. 2019 Nov 27;2019:4705247

Sammanställd av Amaralis Kuhr, grupp 32

Föregående rapport
Electroacupuncture better than biofeedback for myofascial neck pain
Nästa rapport
Akupunktur är effektiv vid profylax och behandling av individer med högt blodtryck